Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3700-0.1900 (-4.17%)
At close: 04:00PM EST
4.4350 +0.07 (+1.49%)
Pre-market: 08:00AM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
351,367
48,633
Operating expenses
Research development
106,738
81,936
167,205
38,023
Selling general and administrative
50,750
48,714
45,785
21,640
Total operating expenses
157,488
130,650
212,990
59,663
Operating income or loss
-157,488
-130,650
138,377
-11,030
Income before tax
-130,431
-119,499
138,590
-10,947
Income tax expense
792
-3,590
17,400
0
Income from continuing operations
-131,223
-115,909
121,190
-10,947
Net income
-131,223
-115,909
121,190
-10,947
Net income available to common shareholders
-131,223
-115,909
121,190
-10,947
Basic EPS
-1.57
-1.39
1.46
-0.51
Diluted EPS
-1.57
-1.39
1.37
-0.51
Basic average shares
83,353
83,245
82,820
21,592
Diluted average shares
83,353
83,245
88,249
21,592